These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38114045)

  • 1. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.
    Carpi M; Palagini L; Fernandes M; Calvello C; Geoffroy PA; Miniati M; Pini S; Gemignani A; Mercuri NB; Liguori C
    Neuropharmacology; 2024 Mar; 245():109815. PubMed ID: 38114045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin Receptor Antagonists and Insomnia.
    Wu X; Xue T; Chen Z; Wang Z; Chen G
    Curr Psychiatry Rep; 2022 Oct; 24(10):509-521. PubMed ID: 35972717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.
    Han Y; Yuan K; Zheng Y; Lu L
    Neurosci Bull; 2020 Apr; 36(4):432-448. PubMed ID: 31782044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?
    Berteotti C; Calvello C; Liguori C
    Epilepsia; 2023 Aug; 64(8):1991-2005. PubMed ID: 37212716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.
    Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics.
    Janto K; Prichard JR; Pusalavidyasagar S
    J Clin Sleep Med; 2018 Aug; 14(8):1399-1408. PubMed ID: 30092886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment.
    Palagini L; Geoffroy PA; Balestrieri M; Miniati M; Biggio G; Liguori C; Menicucci D; Ferini-Strambi L; Nobili L; Riemann D; Gemignani A
    J Sleep Res; 2023 Aug; 32(4):e13825. PubMed ID: 36786121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.
    Kumar A; Chanana P; Choudhary S
    Pharmacol Rep; 2016 Apr; 68(2):231-42. PubMed ID: 26922522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.
    Mahoney CE; Mochizuki T; Scammell TE
    Sleep; 2020 Jun; 43(6):. PubMed ID: 31830270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin OX
    Jacobson LH; Chen S; Mir S; Hoyer D
    Curr Top Behav Neurosci; 2017; 33():105-136. PubMed ID: 27909987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function.
    Bigalke JA; Shan Z; Carter JR
    Hypertension; 2022 Dec; 79(12):2643-2655. PubMed ID: 36148653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
    Muehlan C; Vaillant C; Zenklusen I; Kraehenbuehl S; Dingemanse J
    Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1063-1078. PubMed ID: 32901578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders.
    Boss C; Gatfield J; Brotschi C; Heidmann B; Sifferlen T; von Raumer M; Schmidt G; Williams JT; Treiber A; Roch C
    ChemMedChem; 2020 Dec; 15(23):2286-2305. PubMed ID: 32937014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
    Roecker AJ; Cox CD; Coleman PJ
    J Med Chem; 2016 Jan; 59(2):504-30. PubMed ID: 26317591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of orexin receptor antagonism on human sleep architecture: A systematic review.
    Clark JW; Brian ML; Drummond SPA; Hoyer D; Jacobson LH
    Sleep Med Rev; 2020 Oct; 53():101332. PubMed ID: 32505969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.
    Shariq AS; Rosenblat JD; Alageel A; Mansur RB; Rong C; Ho RC; Ragguett RM; Pan Z; Brietzke E; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():1-7. PubMed ID: 30576764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes and Consequences of Chronic Sleep Deficiency and the Role of Orexin.
    Mullington JM; Cunningham TJ; Haack M; Yang H
    Front Neurol Neurosci; 2021; 45():128-138. PubMed ID: 34052807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review.
    Besterman AD; Jeste SS
    Eur Child Adolesc Psychiatry; 2023 Mar; 32(3):527-531. PubMed ID: 34611728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.